CRYPTOSPORIDIUM PARVUM - ANVISA Registration 80001590006
Access comprehensive regulatory information for CRYPTOSPORIDIUM PARVUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80001590006 and manufactured by TECHLAB, INC. The registration is held by AIMARA COMERCIO E REPRESENTAÇÕES with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, HYSEN BIOTECH.LNC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80001590006
25351391658202284
57202418000107
Company Information
Dates and Status
Oct 20, 2022
VIGENTE
09/18/2025 19:00:01
R-BIOPHARM AG• Germany
HYSEN BIOTECH.LNC• South Korea
REMEL EUROPE LIMITED• United Kingdom
EPITOPE DIAGNOSTICS• United States of America
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA• Brazil
CRYPTOSPORIDIUM PARVUM
Cryptosporidium Antigen Rapid Test Cassette
HYSEN BIOTECH.LNC
80464810924
Jun 30, 2025
CRYPTOSPORIDIUM PARVUM
RIDASCREEN® Cryptosporidium
R-BIOPHARM AG
82890930010
Apr 28, 2025
CRYPTOSPORIDIUM PARVUM
FASTLINE CRYPTOSPORIDIUM Ag
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
80105220131
May 02, 2023
CRYPTOSPORIDIUM PARVUM
RIDASCREEN CRYPTOSPORIDIUM
R-BIOPHARM AG
80826840116
Oct 21, 2019
CRYPTOSPORIDIUM PARVUM
FAMÍLIA RIDA QUICK CRYPTOSPORIDIUM CASSETE/TIRAS
R-BIOPHARM AG
80826840127
Oct 21, 2019

